ThroatGuard PRO

Natural health product licensed in Canada

Other names: BLIS K12(TM)
Licence holder: Blis Technologies Limited
NPN or DIN-HM: 80104821
Status: Active licence
Licence date: 5 October 2020
Revision date: 26 May 2021
Form: Pastille
Route of administration: Orale
Application type: Non traditionnelle

If this product were sold in France

No point flagged by the rules we apply.

A daily quantity is calculated only for an explicit adult oral dosage, stated per day and in a solid unit matching the product form. Ambiguous units, liquids, powders and paediatric doses are not extrapolated. A quantity not calculated is not compared with dose limits. This analysis does not constitute authorisation for sale in France or an assessment of safety or efficacy.

Composition

Medicinal ingredient and source	Per dosage unit, according to the source	Maximum per day, adult
Streptococcus salivarius Source : K12	1 Milliards d'UFC	Not calculated
Streptococcus salivarius Source : Cellule entière	1 Milliards d'UFC	Not calculated

Non-medicinal ingredients

Saveur, Stéarate de magnésium, Trehalose, Isomalt, Lactitol, Maltodextrine, Cellulose microcrystalline silicifiée

Recommended doses in Canada

Population	Age	Quantity per serving	Frequency
Enfants, adolescents et adultes	Not specified	1 Pastille	minimum: 1 Tous les jours ; maximum: 2 Tous les jours

Uses authorised in Canada

Promotes oral health [through the recolonization of the oral cavity]. An oral probiotic for recolonization of the oral cavity after antibiotic treatment. Can help reduce the incidence of Streptococcal pharyngitis/tonsillitis (sore throat caused by pathogenic variants belonging to the Streptococcus pyogenes genus) (in children). Helps support the health of the oral microbiome. Could promote a healthy oral microbiota. An oral probiotic for colonization of the oral cavity. Helps maintain/support healthy mouth flora. Maintain(s)/support(s) oral health. Could promote/enhances/improves healthy mouth flora. Helps (to) restore a healthy bacterial balance in the oral cavity. Helps (to) prevent/reduce risk of infections such as sore throat (pharyngitis/tonsillitis) (in children). Helps (to) reduce the frequency of upper respiratory infections. Helps (to) reduce the frequency of upper respiratory infections caused by certain bacterial and viral microorganisms. Helps (to) reduce the frequency/incidence of otitis media (ear infection) in young children. Maintain(s)/support(s) ear health by reducing the frequency/incidence of otitis media (ear infection). Maintain(s)/support(s) healthy ear function by reducing the frequency/incidence of otitis media (ear infection). Helps to support the immune system.

A use authorised in Canada is not an authorised health claim in the European Union. See the health claims register.

Warnings in Canada

Précautions et mises en garde
Do not use this product if you have an immune-compromised condition (e.g. AIDS, lymphoma, patients undergoing long-term corticosteroid treatment) or a milk/dairy allergy. If symptoms of ear, nose or throat infections (e.g. fever, sore throat) develop, consult a health care practitioner. If you have fever, vomiting, bloody diarrhoea or severe abdominal pain consult a health care practitioner prior to use.

Source

Official Health Canada record, licence 80104821

Licensed Natural Health Products Database (LNHPD), Health Canada: licensed products, ingredients, doses, uses and risks, retrieved 27 October 2026.

Contains information licensed under the Open Government Licence – Canada (Health Canada, LNHPD)

Licence du gouvernement ouvert – Canada 2.0 (OGL-Canada 2.0)

The formula sold in Europe under the same name may differ. This information does not replace advice from a doctor or pharmacist.

List in the official revision dated 26 May 2021 (register: Licensed Natural Health Products Database (LNHPD), Health Canada: licensed products, ingredients, doses, uses and risks).

List recorded in 2021. Photograph the packaging to check whether it has changed. Photograph the packaging